RT Journal Article
SR Electronic
T1 Identifying COVID-19 phenotypes using cluster analysis and assessing their clinical outcomes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.27.22275708
DO 10.1101/2022.05.27.22275708
A1 Yamga, Eric
A1 Mullie, Louis
A1 Durand, Madeleine
A1 Cadrin-Chenevert, Alexandre
A1 Tang, An
A1 Montagnon, Emmanuel
A1 Chartrand-Lefebvre, Carl
A1 Chassé, Michaël
YR 2022
UL http://medrxiv.org/content/early/2022/05/29/2022.05.27.22275708.abstract
AB Multiple clinical phenotypes have been proposed for COVID-19, but few have stemmed from data-driven methods. We aimed to identify distinct phenotypes in patients admitted with COVID-19 using cluster analysis, and compare their respective characteristics and clinical outcomes.We analyzed the data from 547 patients hospitalized with COVID-19 in a Canadian academic hospital from January 1, 2020, to January 30, 2021. We compared four clustering algorithms: K-means, PAM (partition around medoids), divisive and agglomerative hierarchical clustering. We used imaging data and 34 clinical variables collected within the first 24 hours of admission to train our algorithm. We then conducted survival analysis to compare clinical outcomes across phenotypes and trained a classification and regression tree (CART) to facilitate phenotype interpretation and phenotype assignment.We identified three clinical phenotypes, with 61 patients (17%) in Cluster 1, 221 patients (40%) in Cluster 2 and 235 (43%) in Cluster 3. Cluster 2 and Cluster 3 were both characterized by a low-risk respiratory and inflammatory profile, but differed in terms of demographics. Compared with Cluster 3, Cluster 2 comprised older patients with more comorbidities. Cluster 1 represented the group with the most severe clinical presentation, as inferred by the highest rate of hypoxemia and the highest radiological burden. Mortality, mechanical ventilation and ICU admission risk were all significantly different across phenotypes.We conducted a phenotypic analysis of adult inpatients with COVID-19 and identified three distinct phenotypes associated with different clinical outcomes. Further research is needed to determine how to properly incorporate those phenotypes in the management of patients with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementM.C. is supported by a Fonds de Recherche Québec Santé (FRQS) Clinical Research scholarship. M.D. is supported by a FRQS Clinical Research scholarship. A.T. is supported by a FRQS Clinical Research Scholarship and a Fondation de l'Association des Radiologistes du Québec (FARQ) Clinical Research Scholarship. This work was partly funded by a Quebec Bio-Imaging Network research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the CHUM (Centre Hospitalier de l’Université de Montréal) approved the study and informed consent was waived because of its low risk and retrospective nature.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not Applicable I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableThe entire code excluding the dataset is publicly available on GitHub (https://github.com/CODA-19/models/tree/master/phenotyper) The data that support the findings of this study are available on request from the corresponding author, MC.APNaverage proportion of non-overlapADaverage distanceADMaverage distance between meansCARTclassification and regression treeCCICharlson Comorbidity IndexCXRchest radiographsFAMDfactor analysis of mixed dataFOMfigure of meritICUintensive care unitMCIMedicines Comorbidity IndexMVmechanical ventilationNLRneutrophil-to-lymphocyte ratioPAMpartition around medoidsPCRpolymerase chain reactionPOLSTPhysician Orders for Life-Sustaining TreatmentVIAvariable importance analysis